Brookfield Asset Management Inc. Vir Biotechnology, Inc. Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 16, 2022	BUY	$19.08 - $26.7 $1.61 Million - $2.25 Million	84,444 New	84,444 $2.15 Million
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $10,608 - $14,845	-556 Reduced 0.65%	84,444 $2.15 Million
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $476,775 - $900,225	-22,500 Reduced 20.93%	85,000 $2.19 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $3.33 Million - $5.81 Million	107,500 New	107,500 $4.5 Million

215

85.8M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.31B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.